Centenial Surgical Suture

Centenial Surgical Suture

104.30
-6.55
(-5.91%)
Market Cap
38.01 Cr
EPS
-4.01
PE Ratio
49.19
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
189.00
52 Week Low
82.15
PB Ratio
1.40
Debt to Equity
0.85
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
2,041.80
#1 20,688.68
57.78
#1 1,669.83
24.59
#1 357
25.81
49.62
331.95
1,824.47
78.98
236.56
19.23
29
-50.60
26.87
319.40
1,699.41
62.18
392.41
-0.45
30
-55.00
34.87
613.40
1,019.58
62.56
249.37
40.00
17
-20.59
48.35
565.70
912.43
44.62
186.47
61.83
20
-
63.48
583.90
700.90
36.35
67.10
30.58
18
18.92
55.41
231.10
440.01
#1 26.02
136.30
#1 107.77
16
-
80.99
308.00
321.56
39.22
111.60
-1.43
8
-0.10
89.84
299.00
314.35
39.16
89.85
0.60
7
#1 752.54
68.59
257.10
257.10
-
122.10
19.24
1
-52.94
64.97
Forecast
Actual
Growth Rate
Revenue Growth
4.48 %
Net Income Growth
-236.36 %
Cash Flow Change
174.88 %
ROE
-235.23 %
ROCE
-50.12 %
EBITDA Margin (Avg.)
19.00 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
52
52
53
53
56
56
37
45
53
51
54
53
Expenses
47
47
48
48
51
50
32
40
48
46
47
47
EBITDA
5
5
5
5
5
6
5
5
4
5
6
6
Operating Profit %
10 %
9 %
9 %
8 %
9 %
10 %
14 %
10 %
8 %
10 %
12 %
11 %
Depreciation
1
1
1
1
1
2
2
2
1
1
4
4
Interest
2
2
2
1
2
2
2
2
2
3
4
4
Profit Before Tax
3
2
3
2
3
2
2
1
2
1
-2
-2
Tax
1
1
1
1
1
1
1
0
1
0
-0
0
Net Profit
2
2
2
2
2
1
1
1
1
1
-2
-2
EPS in ₹
5.25
4.28
4.71
4.23
5.53
3.55
2.64
1.72
2.43
3.11
-4.01
-5.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
55
53
56
55
57
69
70
61
66
79
85
Fixed Assets
4
4
4
4
4
10
9
8
7
13
20
Current Assets
51
49
52
51
52
58
61
53
59
65
63
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
51
49
52
51
53
59
61
54
60
66
65
Total Liabilities
55
53
56
55
57
69
70
61
66
79
85
Current Liabilities
31
27
28
27
26
31
32
24
29
33
32
Non Current Liabilities
3
3
3
3
3
10
9
7
6
14
22
Total Equity
21
23
25
26
28
29
30
30
31
32
31
Reserve & Surplus
16
17
19
21
23
23
24
25
26
27
25
Share Capital
5
5
5
5
5
5
5
5
5
5
5

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
1
-1
-0
0
-1
0
-0
-0
0
0
-1
Investing Activities
-0
-0
-2
-1
-1
-1
-1
-0
-0
-8
-12
Operating Activities
0
-2
0
2
2
2
2
5
1
6
17
Financing Activities
1
1
2
-1
-1
-0
-1
-5
-1
2
-6

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
44.78 %
45.48 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
46.89 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
53.35 %
53.24 %
53.25 %
53.24 %
53.33 %
53.31 %
53.31 %
53.29 %
52.33 %
51.86 %
51.95 %
51.71 %
51.68 %
50.21 %
50.21 %
50.20 %
50.29 %
50.29 %
Others
1.86 %
1.97 %
1.96 %
1.98 %
1.89 %
1.91 %
1.91 %
1.92 %
2.19 %
1.25 %
1.16 %
1.40 %
1.43 %
2.90 %
2.90 %
2.91 %
2.83 %
2.82 %
No of Share Holders
700
790
799
867
887
888
900
911
894
900
947
1,016
1,072
1,159
1,163
1,186
1,206
1,186

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 108.00 129.50
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 137.70 126.65
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 133.90 120.30
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 133.00 134.75
28 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Jul 2025 145.00 158.45
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 147.45 155.00

Announcements

Clarification On Price Movement2 days ago
Clarification sought from Centenial Surgical Suture Ltd4 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Standalone Un-Audited Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday August 12 2025 Pursuant To Regulation 30 Read With Schedule III(A)(IV) Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015.Aug 12, 2025
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30 2025 As Per Regulation 33 Of The SEBI (LODR) Regulations 2015Aug 05, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 28, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 04, 2025
Letter To Shareholders As Per Requirements Of Regulation 36(1)(B) Of The SEBI (LODR) Regulation 2015 - Annual Report 2024-2025 And 30Th E-AGM NoticeJul 03, 2025
Notice Of 30Th AGMJul 03, 2025
Reg. 34 (1) Annual Report.Jul 03, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 28, 2025
Closure of Trading WindowJun 26, 2025
30Th E-AGM Of The Company On July 28 2025Jun 21, 2025
Notice Of Book Closure As Per Reg 42 Of The SEBI (LODR) Regulations 2015Jun 21, 2025
Announcement Under Regulation 30 (LODR) - Re-Appointment Of Managing Director & Chief Executive OfficerJun 21, 2025
Announcement Under Reg 30 (LODR) - Re-Appointment Of Whole Time DirectorJun 21, 2025
Annoucement Under Reg 30 (LODR) - Appointment Of Internal AuditorJun 21, 2025
Annoucement Under Reg 30 (LODR) - Appointment Of Secretarial AuditorJun 21, 2025
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Appointment Of Internal AuditorJun 21, 2025
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sJun 21, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On June 21 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015Jun 21, 2025
Board Meeting Intimation for AGMJun 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025
Standalone Audited Financial Results For The Quarter And Year Ended March 31 2025May 28, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 28 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations 2015.May 28, 2025
Board Meeting Intimation for Approval Of Standalone Audited Financial Results For The Quarter And Year Ended March 31 2025 As Per Regulation 33 Of The SEBI (LODR) Regulations 2015May 23, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Integrated Filing (Financial)Feb 14, 2025
Standalone Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday February 14 2025 Pursuant To Regulation 30 Read With Schedule III(A)(IV) Of The SEBI (Listing Obligations And Disclosure RequiremeFeb 14, 2025
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations 2015Feb 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Closure of Trading WindowDec 27, 2024
Abnormal Price Rise Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities & Manipulative Trade Observed & Request Urgent Attention For Possible MISUSE / UNETHICALDec 23, 2024
Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise, Which Was Not Supported By Any Corporate Announcements Or Material Changes In The Business Activities & Manipulative Trade Observed - Possible MISUSE / UNETHICAL / UNUSUAL TRADESDec 10, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 28, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2024 Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015.Nov 14, 2024
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024 As Per Regulation 33 Of The SEBI (LODR) Regulations, 2015Nov 07, 2024

Technical Indicators

RSI(14)
Neutral
24.95
ATR(14)
Less Volatile
11.52
STOCH(9,6)
Oversold
6.20
STOCH RSI(14)
Oversold
1.30
MACD(12,26)
Bearish
-4.37
ADX(14)
Weak Trend
14.77
UO(9)
Bearish
30.54
ROC(12)
Downtrend And Accelerating
-32.43
WillR(14)
Oversold
-97.00